Stockreport

GeneDx Reports Fourth Quarter and Full Year 2024 Financial Results and Issues Guidance for Full Year 2025

GeneDx Holdings Corp. - Class A  (WGS) 
PDF Grew fourth quarter 2024 revenues1 to $95.3 millionExpanded fourth quarter 2024 adjusted gross margins1,2 to 70%Generated fourth quarter 2024 adjusted net income2 of $16 [Read more]